Showing 2 posts of 2 posts found.

Advanced melanoma

Novartis and Merck skin cancer drugs move through pipeline

August 20, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Merck, Novartis, Odomzo, basal cell carcinoma, keytruda, melanoma, pembrolizumab, skin cancer, sonidegib

Both Novartis and Merck have hit regulatory milestones with their skin cancer drugs in the EU and the US. Novartis’ …

Novartis image

FDA approves Novartis drug Odomzo

July 27, 2015
Sales and Marketing Novartis, Odomzo, basal cell carcinoma, skin cancer

The FDA has given the Swiss firm the go-ahead to market its drug for skin cancer. Odomzo (sonidegib, formerly LDE225) …

Latest content